Form 8-K - Current report:
SEC Accession No. 0001279569-25-000345
Filing Date
2025-04-03
Accepted
2025-04-03 07:01:21
Documents
13
Period of Report
2025-03-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 25523
  Complete submission text file 0001279569-25-000345.txt   195345

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ffntf-20250329.xsd EX-101.SCH 3093
3 XBRL LABEL FILE ffntf-20250329_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE ffntf-20250329_pre.xml EX-101.PRE 22371
16 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3467
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 25807489
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)